Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 15;879(30):3497-506. doi: 10.1016/j.jchromb.2011.09.031. Epub 2011 Sep 22.

Abstract

This method provides a simple extraction procedure, as well as a validated, sensitive, and specific liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of ampicillin, piperacillin, tazobactam, meropenem, acyclovir, and metronidazole in human plasma. The method was validated over concentration ranges specific for each compound, with a lower limit of quantification of 50-300 ng/mL and a sample volume of 50 μL. The method is accurate and precise, with within- and between-day accuracy ranging from 85 to 110% and 92 to 110%, respectively, and within- and between-day precision of 89-111% and 91-109%, respectively. Simplicity, low plasma volume, and high throughput make this method suitable for clinical pharmacokinetic studies in premature infants.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / blood*
  • Anti-Bacterial Agents / pharmacokinetics
  • Antiviral Agents / blood*
  • Antiviral Agents / pharmacokinetics
  • Chromatography, Liquid / methods*
  • Drug Stability
  • Humans
  • Infant, Newborn
  • Infant, Premature / blood*
  • Regression Analysis
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / methods*

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents